These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Scleromyxedema with laryngeal changes. Beneficial results of the treatment with mucopolysaccharidases]. Cosgarea R; Cosgarea M; Turcu T Ann Dermatol Venereol; 1994; 121(2):159-61. PubMed ID: 7979029 [TBL] [Abstract][Full Text] [Related]
10. Improvement of scleromyxedema associated with isotretinoin therapy. Hisler BM; Savoy LB; Hashimoto K J Am Acad Dermatol; 1991 May; 24(5 Pt 2):854-7. PubMed ID: 2050852 [TBL] [Abstract][Full Text] [Related]
15. Photochemotherapy for systemic and localized scleroderma. De Rie MA; Bos JD J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642 [No Abstract] [Full Text] [Related]
16. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis. Jablonska S; Blaszczyk M Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735 [TBL] [Abstract][Full Text] [Related]
17. [Carnitine and diseases of the connective tissue]. Strack E; Nitschner H; Liebsch F Dtsch Gesundheitsw; 1970 Jun; 25(26):1233-6. PubMed ID: 5515092 [No Abstract] [Full Text] [Related]
19. Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin. Karim A; Lawlor F; Black MM Clin Exp Dermatol; 2004 May; 29(3):317-8. PubMed ID: 15115524 [No Abstract] [Full Text] [Related]
20. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work. Lin YC; Wang HC; Shen JL J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]